<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00402987</url>
  </required_header>
  <id_info>
    <org_study_id>A3191334</org_study_id>
    <nct_id>NCT00402987</nct_id>
  </id_info>
  <brief_title>Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat</brief_title>
  <official_title>A Double Blind, Randomized, Placebo-Controlled Comparison of the Efficacy, Safety, and Tolerability of Celecoxib 100-150 mg, Including Initial Doses of 50 and 100 mg, and Placebo in the Symptomatic Treatment of Patients With Painful Pharyngitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are proposing a study in which we utilize and augment the sore throat pain model to assess
      the analgesic effectiveness of celecoxib compared to placebo in patients with painful
      pharyngitis under randomized, double-blind, placebo-controlled conditions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sum of Sore Throat Pain Intensity Difference (SPID2) on Swallowing at 2 Hours Post-First Dose</measure>
    <time_frame>2 hours Post-First Dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Pain Intensity Difference (PID) Within 6 Hours Post-First Dose</measure>
    <time_frame>Within First 6 hours Post-First Dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Pain Intensity Difference (PID) From 7 to 24 Hours Post-First Dose</measure>
    <time_frame>7 to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sum of Sore Throat Pain Intensity Difference (SPID) Within 6 Hours Post-First Dose</measure>
    <time_frame>up to 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sum of Sore Throat Pain Intensity Difference (SPID) From 7 to 24 Hours Post-First Dose</measure>
    <time_frame>7 to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Relief Rating Scale (STRRS) Within 6 Hours Post-First Dose</measure>
    <time_frame>within the first 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Relief Rating Scale (STRRS) From 7 to 24 Hours Post-First Dose</measure>
    <time_frame>7 to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Relief Rating Scale (STRRS) - 'Moderate Relief' at 6 Hours Post-First Dose</measure>
    <time_frame>at 6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore Throat Relief Rating Scale (STRRS) - 'Moderate Relief' at 12 Hours Post-First Dose</measure>
    <time_frame>12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Perceptible Pain Relief</measure>
    <time_frame>Within 2 Hours Post-First Dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Meaningful Pain Relief</measure>
    <time_frame>Within 2 Hours Post-First Dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Onset of Analgesia</measure>
    <time_frame>Within 2 Hours Post-First Dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's Global Evaluation of Study Medication at 6 Hours Post-First Dose</measure>
    <time_frame>6 Hours Post-First Dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's Global Evaluation of Study Medication at 12 and 24 Hours Post-First Dose</measure>
    <time_frame>12 and 24 hours Post-First Dose</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">269</enrollment>
  <condition>Pharyngitis</condition>
  <arm_group>
    <arm_group_label>celecoxib 50 mg/50 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>celecoxib 100 mg/placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>celecoxib 100 mg/50 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celecoxib</intervention_name>
    <description>dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
    <arm_group_label>celecoxib 50 mg/50 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celecoxib followed by placebo</intervention_name>
    <description>dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 placebo</description>
    <arm_group_label>celecoxib 100 mg/placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celecoxib</intervention_name>
    <description>dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
    <arm_group_label>celecoxib 100 mg/50 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have a diagnosis of pharyngitis with objective findings of
             tonsillo-pharyngitis.

          -  The patient is willing to take &quot;nothing by mouth&quot; including inhaled treatments except
             trial medication during the two hours while at the site and following trial drug
             administration (e.g. not smoking, food, drink, candy, lozenges, chewing gum). The
             patient will be allowed food and drink between hours 2 and 24, but no other oral or
             inhaled treatments such as smoking, lozenges, chewing gum. After the two hour
             assessment, the patients will be allowed food and drink within one half-hour following
             any hourly evaluations sore throat.

        Exclusion Criteria:

          -  The patient has used any analgesic/antipyretic within 1 dosing interval preceding
             administration of the first dose of trial medication.

          -  The patient anticipates using any inhaled therapy including beta-agonists (e.g.,
             ventolin) during the 24 hour trial period and, if used, has only used inhaled therapy
             on an intermittent basis in the week prior to the screening visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Storrs</city>
        <state>Connecticut</state>
        <zip>06269-2011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3191334&amp;StudyName=Testing%20The%20Effectiveness%20Of%20Celecoxib%20In%20Patients%20With%20Painful%20Sore%20Throat.</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2006</study_first_submitted>
  <study_first_submitted_qc>November 22, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2006</study_first_posted>
  <results_first_submitted>November 14, 2008</results_first_submitted>
  <results_first_submitted_qc>February 10, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 12, 2009</results_first_posted>
  <last_update_submitted>June 8, 2009</last_update_submitted>
  <last_update_submitted_qc>June 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>Director, Clinical Trial Disclosure Group</name_title>
    <organization>Pfizer, Inc.</organization>
  </responsible_party>
  <keyword>sore throat</keyword>
  <keyword>acute pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celecoxib</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>1 center in the United States.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Celecoxib 50mg/50mg</title>
          <description>Dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
        </group>
        <group group_id="P2">
          <title>Celecoxib 100mg/Placebo</title>
          <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 placebo</description>
        </group>
        <group group_id="P3">
          <title>Celecoxib 100mg/50mg</title>
          <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
        </group>
        <group group_id="P4">
          <title>Placebo</title>
          <description>Dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="45"/>
                <participants group_id="P4" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="44"/>
                <participants group_id="P4" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Celecoxib 50mg/50mg</title>
          <description>Dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
        </group>
        <group group_id="B2">
          <title>Celecoxib 100mg/Placebo</title>
          <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 placebo</description>
        </group>
        <group group_id="B3">
          <title>Celecoxib 100mg/50mg</title>
          <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
        </group>
        <group group_id="B4">
          <title>Placebo</title>
          <description>Dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="90"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="45"/>
            <count group_id="B4" value="89"/>
            <count group_id="B5" value="269"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.5" spread="1.3"/>
                    <measurement group_id="B2" value="19.6" spread="1.4"/>
                    <measurement group_id="B3" value="19.9" spread="2.3"/>
                    <measurement group_id="B4" value="19.3" spread="1.4"/>
                    <measurement group_id="B5" value="19.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="49"/>
                    <measurement group_id="B5" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sum of Sore Throat Pain Intensity Difference (SPID2) on Swallowing at 2 Hours Post-First Dose</title>
        <description>Based on the Pain Intensity scores measured on a Visual Analogue Scale (PI-VAS: 0mm=no pain,100mm=worst possible pain), assessed by the subjects, the SPID2 is the area under the curve (AUC) over the 2-hour period post-first dose of the Pain Intensity Difference (PID) scores using the trapezoidal rule.</description>
        <time_frame>2 hours Post-First Dose</time_frame>
        <population>Modified intent-to-treat (MITT) population, defined as all subjects randomized to treatment who received at least 1 dose of study drug and had at least 1 post-treatment efficacy assessment. The celecoxib 100mg (pooled) treatment group and placebo were compared for the primary endpoint. Celecoxib 50mg/50mg group was not in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 100mg (Pooled)</title>
            <description>Treatment groups 2 and 3 (celecoxib 100 mg/placebo and celecoxib 100 mg/50 mg) were pooled</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Sum of Sore Throat Pain Intensity Difference (SPID2) on Swallowing at 2 Hours Post-First Dose</title>
          <description>Based on the Pain Intensity scores measured on a Visual Analogue Scale (PI-VAS: 0mm=no pain,100mm=worst possible pain), assessed by the subjects, the SPID2 is the area under the curve (AUC) over the 2-hour period post-first dose of the Pain Intensity Difference (PID) scores using the trapezoidal rule.</description>
          <population>Modified intent-to-treat (MITT) population, defined as all subjects randomized to treatment who received at least 1 dose of study drug and had at least 1 post-treatment efficacy assessment. The celecoxib 100mg (pooled) treatment group and placebo were compared for the primary endpoint. Celecoxib 50mg/50mg group was not in this analysis.</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.0" spread="2.20"/>
                    <measurement group_id="O2" value="9.4" spread="2.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis: No difference in SPID2 (PI-VAS) at two hours between celecoxib 100 mg and placebo. Sample size was based on an expected effect size of 0.42 (from earlier studies), 80% power and an alpha of 0.05.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0003</p_value>
            <method>generalized linear model</method>
            <method_desc>p-value was calculated using Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>11.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>5.5</ci_lower_limit>
            <ci_upper_limit>17.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Pain Intensity Difference (PID) Within 6 Hours Post-First Dose</title>
        <description>Pain intensity (PI) on Swallowing as Measured by PI-VAS scale: 0mm=no pain, 100mm=worst possible pain. Sore throat PID score was obtained by subtracting the PI at each time point from the Baseline PI score. Increase in scores indicated a lessening of subjects' pain compared to baseline scores; higher scores indicated a greater reduction in pain.</description>
        <time_frame>Within First 6 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
            <description>Dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
            <description>Treatment groups 2 and 3 (celecoxib 100 mg/placebo and celecoxib 100 mg/50 mg) were pooled</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Pain Intensity Difference (PID) Within 6 Hours Post-First Dose</title>
          <description>Pain intensity (PI) on Swallowing as Measured by PI-VAS scale: 0mm=no pain, 100mm=worst possible pain. Sore throat PID score was obtained by subtracting the PI at each time point from the Baseline PI score. Increase in scores indicated a lessening of subjects' pain compared to baseline scores; higher scores indicated a greater reduction in pain.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" spread="0.64"/>
                    <measurement group_id="O2" value="1.92" spread="0.64"/>
                    <measurement group_id="O3" value="0.40" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.70" spread="0.90"/>
                    <measurement group_id="O2" value="4.93" spread="0.90"/>
                    <measurement group_id="O3" value="2.14" spread="0.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.57" spread="1.22"/>
                    <measurement group_id="O2" value="7.05" spread="1.23"/>
                    <measurement group_id="O3" value="3.85" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.18" spread="1.47"/>
                    <measurement group_id="O2" value="11.43" spread="1.47"/>
                    <measurement group_id="O3" value="5.34" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.24" spread="1.62"/>
                    <measurement group_id="O2" value="13.24" spread="1.62"/>
                    <measurement group_id="O3" value="6.60" spread="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.39" spread="1.88"/>
                    <measurement group_id="O2" value="17.00" spread="1.88"/>
                    <measurement group_id="O3" value="6.75" spread="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.68" spread="1.99"/>
                    <measurement group_id="O2" value="18.80" spread="1.99"/>
                    <measurement group_id="O3" value="7.41" spread="2.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.63" spread="2.19"/>
                    <measurement group_id="O2" value="21.51" spread="2.19"/>
                    <measurement group_id="O3" value="8.06" spread="2.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.90" spread="2.29"/>
                    <measurement group_id="O2" value="22.21" spread="2.29"/>
                    <measurement group_id="O3" value="9.06" spread="2.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.52" spread="2.31"/>
                    <measurement group_id="O2" value="23.15" spread="2.31"/>
                    <measurement group_id="O3" value="10.35" spread="2.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.12" spread="2.26"/>
                    <measurement group_id="O2" value="23.56" spread="2.26"/>
                    <measurement group_id="O3" value="10.47" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.42" spread="2.24"/>
                    <measurement group_id="O2" value="20.59" spread="2.24"/>
                    <measurement group_id="O3" value="9.04" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.212</p_value>
            <p_value_desc>Analysis at 15 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.056</p_value>
            <p_value_desc>Analysis at 30 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis at 45 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 60 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 75 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 90 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Pain Intensity Difference (PID) From 7 to 24 Hours Post-First Dose</title>
        <description>Pain intensity (PI) on Swallowing as Measured by PI-VAS scale: 0mm=no pain, 100mm=worst possible pain. PID score was obtained by subtracting the PI at each time point from the Baseline PI score. An increase in scores indicated a lessening of subjects' pain as compared to Baseline scores, thus, higher scores indicated a greater reduction in pain.</description>
        <time_frame>7 to 24 hours</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
            <description>Dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
            <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 placebo</description>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
            <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Pain Intensity Difference (PID) From 7 to 24 Hours Post-First Dose</title>
          <description>Pain intensity (PI) on Swallowing as Measured by PI-VAS scale: 0mm=no pain, 100mm=worst possible pain. PID score was obtained by subtracting the PI at each time point from the Baseline PI score. An increase in scores indicated a lessening of subjects' pain as compared to Baseline scores, thus, higher scores indicated a greater reduction in pain.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.82" spread="2.30"/>
                    <measurement group_id="O2" value="22.01" spread="3.26"/>
                    <measurement group_id="O3" value="18.34" spread="3.25"/>
                    <measurement group_id="O4" value="9.32" spread="2.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.39" spread="2.29"/>
                    <measurement group_id="O2" value="20.81" spread="3.24"/>
                    <measurement group_id="O3" value="19.93" spread="3.23"/>
                    <measurement group_id="O4" value="8.12" spread="2.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.39" spread="2.36"/>
                    <measurement group_id="O2" value="19.18" spread="3.35"/>
                    <measurement group_id="O3" value="18.87" spread="3.33"/>
                    <measurement group_id="O4" value="9.92" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.26" spread="2.40"/>
                    <measurement group_id="O2" value="18.02" spread="3.40"/>
                    <measurement group_id="O3" value="18.06" spread="3.39"/>
                    <measurement group_id="O4" value="9.56" spread="2.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.65" spread="2.40"/>
                    <measurement group_id="O2" value="17.43" spread="3.40"/>
                    <measurement group_id="O3" value="18.99" spread="3.39"/>
                    <measurement group_id="O4" value="9.29" spread="2.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.01" spread="2.50"/>
                    <measurement group_id="O2" value="15.01" spread="3.54"/>
                    <measurement group_id="O3" value="20.22" spread="3.52"/>
                    <measurement group_id="O4" value="8.60" spread="2.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.43" spread="2.58"/>
                    <measurement group_id="O2" value="16.50" spread="3.66"/>
                    <measurement group_id="O3" value="19.44" spread="3.65"/>
                    <measurement group_id="O4" value="12.81" spread="2.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Overall P-value</p_value_desc>
            <method>Generalized Linear Model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <p_value_desc>Analysis at 9 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <p_value_desc>Analysis at 10 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.014</p_value>
            <p_value_desc>Analysis at 11 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Analysis at 12 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.365</p_value>
            <p_value_desc>Analysis at 24 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sum of Sore Throat Pain Intensity Difference (SPID) Within 6 Hours Post-First Dose</title>
        <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The PID [based on PI-VAS scale: 0mm=no pain, 100mm=worst possible pain] was calculated as the difference between the pain intensity at the time and at baseline.</description>
        <time_frame>up to 6 hours</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Sore Throat Pain Intensity Difference (SPID) Within 6 Hours Post-First Dose</title>
          <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The PID [based on PI-VAS scale: 0mm=no pain, 100mm=worst possible pain] was calculated as the difference between the pain intensity at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.2"/>
                    <measurement group_id="O2" value="1.1" spread="0.2"/>
                    <measurement group_id="O3" value="0.4" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="0.4"/>
                    <measurement group_id="O2" value="2.6" spread="0.4"/>
                    <measurement group_id="O3" value="1.1" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="0.7"/>
                    <measurement group_id="O2" value="4.9" spread="0.7"/>
                    <measurement group_id="O3" value="2.3" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="1.0"/>
                    <measurement group_id="O2" value="8.0" spread="1.0"/>
                    <measurement group_id="O3" value="3.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1" spread="1.4"/>
                    <measurement group_id="O2" value="11.8" spread="1.4"/>
                    <measurement group_id="O3" value="5.4" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" spread="1.8"/>
                    <measurement group_id="O2" value="16.2" spread="1.8"/>
                    <measurement group_id="O3" value="7.2" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4" spread="2.3"/>
                    <measurement group_id="O2" value="21.3" spread="2.3"/>
                    <measurement group_id="O3" value="9.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.7" spread="4.3"/>
                    <measurement group_id="O2" value="43.1" spread="4.3"/>
                    <measurement group_id="O3" value="17.7" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.4" spread="6.5"/>
                    <measurement group_id="O2" value="65.8" spread="6.5"/>
                    <measurement group_id="O3" value="27.4" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.2" spread="8.5"/>
                    <measurement group_id="O2" value="89.2" spread="8.5"/>
                    <measurement group_id="O3" value="37.8" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128.0" spread="10.5"/>
                    <measurement group_id="O2" value="111.2" spread="10.5"/>
                    <measurement group_id="O3" value="47.6" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.180</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized Linear Model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.069</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.096</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.034</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.022</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.741</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.759</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.775</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.561</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.419</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.237</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.146</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.113</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.086</p_value>
            <p_value_desc>Analyaia at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.111</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.183</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.259</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sum of Sore Throat Pain Intensity Difference (SPID) From 7 to 24 Hours Post-First Dose</title>
        <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The PID [based on PI-VAS scale: 0mm=no pain, 100mm=worst possible pain] was calculated as the difference between the pain intensity at the time and at baseline.</description>
        <time_frame>7 to 24 hours</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg / Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg / 50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Sore Throat Pain Intensity Difference (SPID) From 7 to 24 Hours Post-First Dose</title>
          <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The PID [based on PI-VAS scale: 0mm=no pain, 100mm=worst possible pain] was calculated as the difference between the pain intensity at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149.2" spread="12.4"/>
                    <measurement group_id="O2" value="151.8" spread="17.5"/>
                    <measurement group_id="O3" value="111.6" spread="17.5"/>
                    <measurement group_id="O4" value="56.6" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169.8" spread="14.3"/>
                    <measurement group_id="O2" value="173.2" spread="20.3"/>
                    <measurement group_id="O3" value="130.8" spread="20.2"/>
                    <measurement group_id="O4" value="65.4" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="190.7" spread="16.3"/>
                    <measurement group_id="O2" value="193.2" spread="23.1"/>
                    <measurement group_id="O3" value="150.2" spread="23.0"/>
                    <measurement group_id="O4" value="74.4" spread="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="212.0" spread="18.2"/>
                    <measurement group_id="O2" value="211.8" spread="25.9"/>
                    <measurement group_id="O3" value="168.6" spread="25.8"/>
                    <measurement group_id="O4" value="84.1" spread="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="232.4" spread="20.2"/>
                    <measurement group_id="O2" value="229.5" spread="28.7"/>
                    <measurement group_id="O3" value="187.2" spread="28.6"/>
                    <measurement group_id="O4" value="93.5" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="251.8" spread="22.3"/>
                    <measurement group_id="O2" value="245.7" spread="31.6"/>
                    <measurement group_id="O3" value="206.8" spread="31.5"/>
                    <measurement group_id="O4" value="102.5" spread="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="476.4" spread="48.7"/>
                    <measurement group_id="O2" value="434.8" spread="69.0"/>
                    <measurement group_id="O3" value="444.7" spread="68.8"/>
                    <measurement group_id="O4" value="231.0" spread="49.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.017</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.011</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.904</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.891</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.929</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.994</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.933</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.876</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.622</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.081</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.117</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.152</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.171</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.197</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.244</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.708</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.106</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.140</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.188</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.239</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.297</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.383</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.919</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Relief Rating Scale (STRRS) Within 6 Hours Post-First Dose</title>
        <description>STRRS score (scale: 0 no relief to 6 complete relief); a higher pain score indicated a greater reduction in pain.</description>
        <time_frame>within the first 6 hours</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Relief Rating Scale (STRRS) Within 6 Hours Post-First Dose</title>
          <description>STRRS score (scale: 0 no relief to 6 complete relief); a higher pain score indicated a greater reduction in pain.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.04"/>
                    <measurement group_id="O2" value="0.09" spread="0.04"/>
                    <measurement group_id="O3" value="0.16" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="0.07"/>
                    <measurement group_id="O2" value="0.34" spread="0.07"/>
                    <measurement group_id="O3" value="0.34" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="0.09"/>
                    <measurement group_id="O2" value="0.69" spread="0.09"/>
                    <measurement group_id="O3" value="0.52" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" spread="0.12"/>
                    <measurement group_id="O2" value="1.01" spread="0.12"/>
                    <measurement group_id="O3" value="0.64" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.58" spread="0.13"/>
                    <measurement group_id="O2" value="1.27" spread="0.13"/>
                    <measurement group_id="O3" value="0.79" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="0.15"/>
                    <measurement group_id="O2" value="1.61" spread="0.15"/>
                    <measurement group_id="O3" value="0.88" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.10" spread="0.16"/>
                    <measurement group_id="O2" value="1.74" spread="0.16"/>
                    <measurement group_id="O3" value="0.93" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.22" spread="0.17"/>
                    <measurement group_id="O2" value="1.93" spread="0.17"/>
                    <measurement group_id="O3" value="0.92" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="0.17"/>
                    <measurement group_id="O2" value="1.92" spread="0.17"/>
                    <measurement group_id="O3" value="0.92" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.08" spread="0.17"/>
                    <measurement group_id="O2" value="1.96" spread="0.17"/>
                    <measurement group_id="O3" value="1.10" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.00" spread="0.17"/>
                    <measurement group_id="O2" value="1.97" spread="0.17"/>
                    <measurement group_id="O3" value="1.07" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.81" spread="0.17"/>
                    <measurement group_id="O2" value="1.86" spread="0.17"/>
                    <measurement group_id="O3" value="0.96" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.537</p_value>
            <p_value_desc>Analysis at 15 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.697</p_value>
            <p_value_desc>Analysis at 30 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.203</p_value>
            <p_value_desc>Analysis at 45 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis at 60 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 75 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 90 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Relief Rating Scale (STRRS) From 7 to 24 Hours Post-First Dose</title>
        <description>STRRS score (scale: 0 no relief to 6 complete relief); a higher score indicated a greater reduction in pain.</description>
        <time_frame>7 to 24 hours</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg / Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg / 50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Relief Rating Scale (STRRS) From 7 to 24 Hours Post-First Dose</title>
          <description>STRRS score (scale: 0 no relief to 6 complete relief); a higher score indicated a greater reduction in pain.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.71" spread="0.17"/>
                    <measurement group_id="O2" value="2.00" spread="0.24"/>
                    <measurement group_id="O3" value="1.67" spread="0.24"/>
                    <measurement group_id="O4" value="0.93" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.68" spread="0.17"/>
                    <measurement group_id="O2" value="1.80" spread="0.24"/>
                    <measurement group_id="O3" value="1.71" spread="0.24"/>
                    <measurement group_id="O4" value="0.97" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.69" spread="0.17"/>
                    <measurement group_id="O2" value="1.76" spread="0.25"/>
                    <measurement group_id="O3" value="1.56" spread="0.25"/>
                    <measurement group_id="O4" value="1.08" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.74" spread="0.17"/>
                    <measurement group_id="O2" value="1.67" spread="0.25"/>
                    <measurement group_id="O3" value="1.51" spread="0.25"/>
                    <measurement group_id="O4" value="1.08" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.67" spread="0.18"/>
                    <measurement group_id="O2" value="1.58" spread="0.25"/>
                    <measurement group_id="O3" value="1.60" spread="0.25"/>
                    <measurement group_id="O4" value="1.10" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.56" spread="0.18"/>
                    <measurement group_id="O2" value="1.42" spread="0.25"/>
                    <measurement group_id="O3" value="1.53" spread="0.25"/>
                    <measurement group_id="O4" value="1.07" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.69" spread="0.19"/>
                    <measurement group_id="O2" value="1.62" spread="0.27"/>
                    <measurement group_id="O3" value="1.60" spread="0.27"/>
                    <measurement group_id="O4" value="1.31" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis at 8 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.046</p_value>
            <p_value_desc>Analysis at 9 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.046</p_value>
            <p_value_desc>Analysis at 10 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.111</p_value>
            <p_value_desc>Analysis at 11 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.226</p_value>
            <p_value_desc>Analysis at 12 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.537</p_value>
            <p_value_desc>Analysis at 24 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Relief Rating Scale (STRRS) - Moderate Relief at 6 Hours Post-First Dose</title>
        <description>Subjects Achieving at Least Moderate Relief as Measured by STRRS (range: 0=no relief to 6=complete relief); Moderate relief is defined as STRRS = 3).</description>
        <time_frame>at 6 hours</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Relief Rating Scale (STRRS) - Moderate Relief at 6 Hours Post-First Dose</title>
          <description>Subjects Achieving at Least Moderate Relief as Measured by STRRS (range: 0=no relief to 6=complete relief); Moderate relief is defined as STRRS = 3).</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.3</ci_lower_limit>
            <ci_upper_limit>5.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.5</ci_lower_limit>
            <ci_upper_limit>6.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.634</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.16</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.6</ci_lower_limit>
            <ci_upper_limit>2.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sore Throat Relief Rating Scale (STRRS) - Moderate Relief at 12 Hours Post-First Dose</title>
        <description>Subjects Achieving at Least Moderate Relief as Measured by STRRS (range: 0=no relief to 6=complete relief); Moderate relief is defined as STRRS = 3).</description>
        <time_frame>12 hours</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg / Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg / 50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Relief Rating Scale (STRRS) - Moderate Relief at 12 Hours Post-First Dose</title>
          <description>Subjects Achieving at Least Moderate Relief as Measured by STRRS (range: 0=no relief to 6=complete relief); Moderate relief is defined as STRRS = 3).</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.202</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.63</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.8</ci_lower_limit>
            <ci_upper_limit>3.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.077</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>5.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.134</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.95</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.8</ci_lower_limit>
            <ci_upper_limit>4.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.671</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>1.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.484</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.75</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.3</ci_lower_limit>
            <ci_upper_limit>1.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.814</p_value>
            <p_value_desc>Treatment as a factor</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>2.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Perceptible Pain Relief</title>
        <description>Defined as time (measured by stopwatch) when subject began to feel any pain relieving effect from the drug</description>
        <time_frame>Within 2 Hours Post-First Dose</time_frame>
        <population>MITT population.
Number of Subjects achieving perceptible pain relief: 77 for celecoxib 50mg/50mg; 67 for celecoxib 100mg (pooled); 46 for placebo
Upper 95% CI for placebo group was &gt;120</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Time to Perceptible Pain Relief</title>
          <description>Defined as time (measured by stopwatch) when subject began to feel any pain relieving effect from the drug</description>
          <population>MITT population.
Number of Subjects achieving perceptible pain relief: 77 for celecoxib 50mg/50mg; 67 for celecoxib 100mg (pooled); 46 for placebo
Upper 95% CI for placebo group was &gt;120</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49" lower_limit="45" upper_limit="61"/>
                    <measurement group_id="O2" value="61" lower_limit="46" upper_limit="75"/>
                    <measurement group_id="O3" value="97" lower_limit="62" upper_limit="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience perceptible pain relief within 2 hours post-first dose, the time to perceptible pain relief was censored at 2 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to perceptible pain relief</p_value_desc>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience perceptible pain relief within 2 hours post-first dose, the time to perceptible pain relief was censored at 2 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to perceptible pain relief</p_value_desc>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience perceptible pain relief within 2 hours post-first dose, the time to perceptible pain relief was censored at 2 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to perceptible pain relief</p_value_desc>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Meaningful Pain Relief</title>
        <description>The time (measured by stopwatch) when the subject felt their pain relief was meaningful to them was not estimable thus the number of subjects experiencing meaningful pain relief within 2 hours of first dose is reported</description>
        <time_frame>Within 2 Hours Post-First Dose</time_frame>
        <population>MITT population.
The median time to meaningful pain relief, including all subjects, was &gt;2 hours in each group (time was censored at 2 hours)
Median time and CI were not estimable</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Time to Meaningful Pain Relief</title>
          <description>The time (measured by stopwatch) when the subject felt their pain relief was meaningful to them was not estimable thus the number of subjects experiencing meaningful pain relief within 2 hours of first dose is reported</description>
          <population>MITT population.
The median time to meaningful pain relief, including all subjects, was &gt;2 hours in each group (time was censored at 2 hours)
Median time and CI were not estimable</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience meaningful pain relief within 2 hours post-first dose, the time to meaningful pain relief was censored at 2 hours.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to meaningful pain relief</p_value_desc>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience meaningful pain relief within 2 hours post-first dose, the time to meaningful pain relief was censored at 2 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to meaningful pain relief</p_value_desc>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Onset of Analgesia</title>
        <description>Equal to time of perceptible pain relief when both perceptible pain relief and meaningful pain relief were experienced- the median time was not estimable thus the number of subjects with onset of analgesia within 2 hours of first dose is reported</description>
        <time_frame>Within 2 Hours Post-First Dose</time_frame>
        <population>MITT population.
The median time to onset of analgesia, including all subjects, was &gt;2 hours in each group (time was censored at 2 hours).
Median time and CI were not estimable.</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Time to Onset of Analgesia</title>
          <description>Equal to time of perceptible pain relief when both perceptible pain relief and meaningful pain relief were experienced- the median time was not estimable thus the number of subjects with onset of analgesia within 2 hours of first dose is reported</description>
          <population>MITT population.
The median time to onset of analgesia, including all subjects, was &gt;2 hours in each group (time was censored at 2 hours).
Median time and CI were not estimable.</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience onset of analgesia within 2 hours post-first dose, the time to onset of analgesia was censored at 2 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to onset of analgesia</p_value_desc>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For subjects who did not experience onset of analgesia within 2 hours post-first dose, the time to onset of analgesia was censored at 2 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>p-value for distribution of time to onset of analgesia</p_value_desc>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients Global Evaluation of Study Medication at 6 Hours Post-First Dose</title>
        <description>Subject assessment of overall impression of study drug on 4 point scale from 1 (poor) to 4 (excellent)</description>
        <time_frame>6 Hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Patients Global Evaluation of Study Medication at 6 Hours Post-First Dose</title>
          <description>Subject assessment of overall impression of study drug on 4 point scale from 1 (poor) to 4 (excellent)</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Excellent (4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good (3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fair (2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor (1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Overall test of Celecoxib 50mg/50mg versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Overall test of Celecoxib 100mg (pooled) versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.889</p_value>
            <p_value_desc>Overall test of Celecoxib 50mg/50mg versus Celecoxib 100mg (pooled) that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients Global Evaluation of Study Medication at 12 and 24 Hours Post-First Dose</title>
        <description>Subject assessment of overall impression of study drug on 4 point scale from 1 (poor) to 4 (excellent)</description>
        <time_frame>12 and 24 hours Post-First Dose</time_frame>
        <population>Subjects analyzed at 24 hours were different for 2 groups: Celecoxib 100mg/Placebo=45 and Placebo=87.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100 mg / Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg / 50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Patients Global Evaluation of Study Medication at 12 and 24 Hours Post-First Dose</title>
          <description>Subject assessment of overall impression of study drug on 4 point scale from 1 (poor) to 4 (excellent)</description>
          <population>Subjects analyzed at 24 hours were different for 2 groups: Celecoxib 100mg/Placebo=45 and Placebo=87.
MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="85"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Excellent (4) - 12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good (3) - 12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fair (2) - 12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor (1) - 12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Excellent (4) - 24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good (3) - 24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fair (2) - 24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor (1) - 24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Overall test of Celecoxib 50mg/50mg versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 12 hours
Overall test of Celecoxib 100mg/Placebo versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>Analysis at 12 hours Overall test of Celecoxib 100mg/50mg versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.411</p_value>
            <p_value_desc>Analysis at 12 hours
Overall test of Celecoxib 50mg/50mg versus Celecoxib 100mg/50mg that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.930</p_value>
            <p_value_desc>Analysis at 12 hours
Overall test of Celecoxib 50mg/50mg versus Celecoxib 100mg/Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.438</p_value>
            <p_value_desc>Analysis at 12 hours
Overall test of Celecoxib 100mg/Placebo versus Celecoxib 100mg/50mg that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 24 hours
Overall test of Celecoxib 50mg/50mg versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.013</p_value>
            <p_value_desc>Analysis at 24 hours
Overall test of Celecoxib 100mg/Placebo versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>Analysis at 24 hours
Overall test of Celecoxib 100mg/50mg versus Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.748</p_value>
            <p_value_desc>Analysis at 24 hours
Overall test of Celecoxib 50mg/50mg versus Celecoxib 100mg/50mg that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.958</p_value>
            <p_value_desc>Analysis at 24 hours
Overall test of Celecoxib 50mg/50mg versus Celecoxib 100mg/Placebo that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.747</p_value>
            <p_value_desc>Analysis at 24 hours
Overall test of Celecoxib 100mg/Placebo versus Celecoxib 100mg/50mg that takes into account the ordered data (categories: excellent, good, fair, poor).</p_value_desc>
            <method>Mantel Haenszel</method>
            <method_desc>Test of row mean score differences based on modified ridits (standardizing the mid-rank)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Throat Soreness Scale (TSS) Difference Within 6 Hours Post-First Dose</title>
        <description>The Pain Intensity Difference (PID) based on TSS (scale: 0=not sore to 10=very sore) was calculated as the difference between the pain intensity at the time and at baseline.</description>
        <time_frame>Within first 6 hours post-first dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Throat Soreness Scale (TSS) Difference Within 6 Hours Post-First Dose</title>
          <description>The Pain Intensity Difference (PID) based on TSS (scale: 0=not sore to 10=very sore) was calculated as the difference between the pain intensity at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.04"/>
                    <measurement group_id="O2" value="0.06" spread="0.04"/>
                    <measurement group_id="O3" value="0.06" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="0.08"/>
                    <measurement group_id="O2" value="0.36" spread="0.08"/>
                    <measurement group_id="O3" value="0.29" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="0.10"/>
                    <measurement group_id="O2" value="0.66" spread="0.10"/>
                    <measurement group_id="O3" value="0.43" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.17" spread="0.13"/>
                    <measurement group_id="O2" value="0.97" spread="0.13"/>
                    <measurement group_id="O3" value="0.60" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" spread="0.15"/>
                    <measurement group_id="O2" value="1.29" spread="0.15"/>
                    <measurement group_id="O3" value="0.75" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.97" spread="0.17"/>
                    <measurement group_id="O2" value="1.64" spread="0.17"/>
                    <measurement group_id="O3" value="0.76" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.24" spread="0.18"/>
                    <measurement group_id="O2" value="1.86" spread="0.18"/>
                    <measurement group_id="O3" value="0.79" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.39" spread="0.19"/>
                    <measurement group_id="O2" value="2.03" spread="0.19"/>
                    <measurement group_id="O3" value="0.78" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.43" spread="0.20"/>
                    <measurement group_id="O2" value="2.09" spread="0.20"/>
                    <measurement group_id="O3" value="0.85" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.14" spread="0.21"/>
                    <measurement group_id="O2" value="2.12" spread="0.21"/>
                    <measurement group_id="O3" value="1.01" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.03" spread="0.20"/>
                    <measurement group_id="O2" value="2.06" spread="0.21"/>
                    <measurement group_id="O3" value="1.04" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.83" spread="0.20"/>
                    <measurement group_id="O2" value="1.90" spread="0.20"/>
                    <measurement group_id="O3" value="0.90" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.999</p_value>
            <p_value_desc>Analysis at 15 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.609</p_value>
            <p_value_desc>Analysis at 30 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.076</p_value>
            <p_value_desc>Analysis at 45 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Analysis at 60 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 75 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 90 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Continuous data were analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Throat Soreness Scale (TSS) Difference From 7 to 24 Hours Post-First Dose</title>
        <description>The Pain Intensity Difference (PID) based on TSS (scale: 0=not sore to 10=very sore) was calculated as the difference between the pain intensity at the time and at baseline.</description>
        <time_frame>7 to 24 hours post-first dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Throat Soreness Scale (TSS) Difference From 7 to 24 Hours Post-First Dose</title>
          <description>The Pain Intensity Difference (PID) based on TSS (scale: 0=not sore to 10=very sore) was calculated as the difference between the pain intensity at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.65" spread="0.21"/>
                    <measurement group_id="O2" value="1.95" spread="0.30"/>
                    <measurement group_id="O3" value="1.68" spread="0.29"/>
                    <measurement group_id="O4" value="0.78" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.67" spread="0.21"/>
                    <measurement group_id="O2" value="1.65" spread="0.30"/>
                    <measurement group_id="O3" value="1.70" spread="0.30"/>
                    <measurement group_id="O4" value="0.76" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.76" spread="0.22"/>
                    <measurement group_id="O2" value="1.60" spread="0.32"/>
                    <measurement group_id="O3" value="1.65" spread="0.32"/>
                    <measurement group_id="O4" value="0.90" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.80" spread="0.23"/>
                    <measurement group_id="O2" value="1.58" spread="0.33"/>
                    <measurement group_id="O3" value="1.63" spread="0.32"/>
                    <measurement group_id="O4" value="0.87" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.76" spread="0.23"/>
                    <measurement group_id="O2" value="1.53" spread="0.32"/>
                    <measurement group_id="O3" value="1.76" spread="0.32"/>
                    <measurement group_id="O4" value="0.87" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.53" spread="0.23"/>
                    <measurement group_id="O2" value="1.37" spread="0.33"/>
                    <measurement group_id="O3" value="1.80" spread="0.33"/>
                    <measurement group_id="O4" value="0.82" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" spread="0.25"/>
                    <measurement group_id="O2" value="1.46" spread="0.36"/>
                    <measurement group_id="O3" value="1.78" spread="0.35"/>
                    <measurement group_id="O4" value="1.17" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis at 7 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>Analysis at 8 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.043</p_value>
            <p_value_desc>Analysis at 9 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.032</p_value>
            <p_value_desc>Analysis at 10 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.029</p_value>
            <p_value_desc>Analysis at 11 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.066</p_value>
            <p_value_desc>Analysis at 12 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.482</p_value>
            <p_value_desc>Analysis at 24 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Sore Throat Pain Intensity Difference (SPID2) as Measured by Throat Soreness Scale (TSS) at 2 Hours Post-First Dose</title>
        <description>SPID2 was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Sore Throat PID was calculated as the difference between the pain intensity (TSS scale: 0=not sore to 10=very sore) at 2 hours post dose and at baseline.</description>
        <time_frame>2 hour period Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sore Throat Pain Intensity Difference (SPID2) as Measured by Throat Soreness Scale (TSS) at 2 Hours Post-First Dose</title>
          <description>SPID2 was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Sore Throat PID was calculated as the difference between the pain intensity (TSS scale: 0=not sore to 10=very sore) at 2 hours post dose and at baseline.</description>
          <population>MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.21"/>
                    <measurement group_id="O2" value="2.0" spread="0.21"/>
                    <measurement group_id="O3" value="1.0" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.8</ci_lower_limit>
            <ci_upper_limit>1.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>1.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.186</p_value>
            <p_value_desc>Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-1.0</ci_lower_limit>
            <ci_upper_limit>0.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Sum of Throat Soreness Difference as Measured by Throat Soreness Scale (TSS) Within 6 Hours Post-First Dose</title>
        <description>The sum of sore throat pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Sore Throat PID was calculated as the difference between the pain intensity (TSS range: 0=not sore to 10=very sore) at the time and at baseline.</description>
        <time_frame>Within 6 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population
At 15min the SE was &lt;0.01 for all 3 groups</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Throat Soreness Difference as Measured by Throat Soreness Scale (TSS) Within 6 Hours Post-First Dose</title>
          <description>The sum of sore throat pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Sore Throat PID was calculated as the difference between the pain intensity (TSS range: 0=not sore to 10=very sore) at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population
At 15min the SE was &lt;0.01 for all 3 groups</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.01"/>
                    <measurement group_id="O2" value="0.01" spread="0.01"/>
                    <measurement group_id="O3" value="0.01" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.02"/>
                    <measurement group_id="O2" value="0.06" spread="0.02"/>
                    <measurement group_id="O3" value="0.05" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.03"/>
                    <measurement group_id="O2" value="0.19" spread="0.03"/>
                    <measurement group_id="O3" value="0.14" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" spread="0.06"/>
                    <measurement group_id="O2" value="0.39" spread="0.06"/>
                    <measurement group_id="O3" value="0.27" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" spread="0.09"/>
                    <measurement group_id="O2" value="0.67" spread="0.09"/>
                    <measurement group_id="O3" value="0.44" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.24" spread="0.13"/>
                    <measurement group_id="O2" value="1.04" spread="0.13"/>
                    <measurement group_id="O3" value="0.63" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.77" spread="0.16"/>
                    <measurement group_id="O2" value="1.48" spread="0.16"/>
                    <measurement group_id="O3" value="0.82" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.35" spread="0.21"/>
                    <measurement group_id="O2" value="1.96" spread="0.21"/>
                    <measurement group_id="O3" value="1.02" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.76" spread="0.39"/>
                    <measurement group_id="O2" value="4.02" spread="0.39"/>
                    <measurement group_id="O3" value="1.83" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.05" spread="0.58"/>
                    <measurement group_id="O2" value="6.12" spread="0.58"/>
                    <measurement group_id="O3" value="2.76" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.13" spread="0.76"/>
                    <measurement group_id="O2" value="8.21" spread="0.77"/>
                    <measurement group_id="O3" value="3.79" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.07" spread="0.94"/>
                    <measurement group_id="O2" value="10.20" spread="0.94"/>
                    <measurement group_id="O3" value="4.75" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.961</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.985</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.975</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.532</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.690</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.820</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.180</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.344</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.693</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.039</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.154</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.521</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.070</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.344</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.022</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.249</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.205</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.186</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.179</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.259</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.393</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.512</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Sum of Throat Soreness Difference as Measured by Throat Soreness Scale (TSS) From 7 to 24 Hours Post-First Dose</title>
        <description>The sum of sore throat pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Sore Throat PID was calculated as the difference between the pain intensity (TSS range: 0=not sore to 10=very sore) at the time and at baseline.</description>
        <time_frame>7 to 24 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Throat Soreness Difference as Measured by Throat Soreness Scale (TSS) From 7 to 24 Hours Post-First Dose</title>
          <description>The sum of sore throat pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Sore Throat PID was calculated as the difference between the pain intensity (TSS range: 0=not sore to 10=very sore) at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8" spread="1.1"/>
                    <measurement group_id="O2" value="14.2" spread="1.6"/>
                    <measurement group_id="O3" value="9.9" spread="1.6"/>
                    <measurement group_id="O4" value="5.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.5" spread="1.3"/>
                    <measurement group_id="O2" value="16.0" spread="1.8"/>
                    <measurement group_id="O3" value="11.6" spread="1.8"/>
                    <measurement group_id="O4" value="6.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2" spread="1.5"/>
                    <measurement group_id="O2" value="17.7" spread="2.1"/>
                    <measurement group_id="O3" value="13.3" spread="2.1"/>
                    <measurement group_id="O4" value="7.2" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.0" spread="1.7"/>
                    <measurement group_id="O2" value="19.3" spread="2.4"/>
                    <measurement group_id="O3" value="14.9" spread="2.3"/>
                    <measurement group_id="O4" value="8.1" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.7" spread="1.8"/>
                    <measurement group_id="O2" value="20.8" spread="2.6"/>
                    <measurement group_id="O3" value="16.6" spread="2.6"/>
                    <measurement group_id="O4" value="8.9" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.4" spread="2.0"/>
                    <measurement group_id="O2" value="22.3" spread="2.9"/>
                    <measurement group_id="O3" value="18.4" spread="2.9"/>
                    <measurement group_id="O4" value="9.8" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.3" spread="4.5"/>
                    <measurement group_id="O2" value="39.2" spread="6.4"/>
                    <measurement group_id="O3" value="39.8" spread="6.4"/>
                    <measurement group_id="O4" value="21.7" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.026</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.463</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.131</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.053</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.020</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.484</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.197</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.086</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.018</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.561</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.252</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.136</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.018</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.653</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.287</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.191</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.018</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.741</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.326</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.256</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.016</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.808</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.394</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.343</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.029</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.023</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.892</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.952</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.948</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) Within 6 Hours Post-First Dose</title>
        <description>The Difficulty Swallowing Pain Intensity Difference (PID) was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
        <time_frame>Within 6 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) Within 6 Hours Post-First Dose</title>
          <description>The Difficulty Swallowing Pain Intensity Difference (PID) was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.69" spread="0.89"/>
                    <measurement group_id="O2" value="1.16" spread="0.89"/>
                    <measurement group_id="O3" value="0.81" spread="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.85" spread="1.21"/>
                    <measurement group_id="O2" value="3.14" spread="1.21"/>
                    <measurement group_id="O3" value="1.11" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.99" spread="1.43"/>
                    <measurement group_id="O2" value="5.75" spread="1.43"/>
                    <measurement group_id="O3" value="2.85" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.21" spread="1.65"/>
                    <measurement group_id="O2" value="8.02" spread="1.65"/>
                    <measurement group_id="O3" value="3.53" spread="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.31" spread="1.84"/>
                    <measurement group_id="O2" value="10.47" spread="1.84"/>
                    <measurement group_id="O3" value="3.95" spread="1.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.40" spread="1.99"/>
                    <measurement group_id="O2" value="12.21" spread="1.99"/>
                    <measurement group_id="O3" value="3.97" spread="2.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.52" spread="2.11"/>
                    <measurement group_id="O2" value="15.15" spread="2.11"/>
                    <measurement group_id="O3" value="4.45" spread="2.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.76" spread="2.25"/>
                    <measurement group_id="O2" value="16.50" spread="2.25"/>
                    <measurement group_id="O3" value="4.99" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.20" spread="2.17"/>
                    <measurement group_id="O2" value="18.39" spread="2.17"/>
                    <measurement group_id="O3" value="4.20" spread="2.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.53" spread="2.33"/>
                    <measurement group_id="O2" value="18.27" spread="2.33"/>
                    <measurement group_id="O3" value="7.28" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.40" spread="2.31"/>
                    <measurement group_id="O2" value="18.11" spread="2.31"/>
                    <measurement group_id="O3" value="6.02" spread="2.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.62" spread="2.27"/>
                    <measurement group_id="O2" value="16.43" spread="2.27"/>
                    <measurement group_id="O3" value="5.70" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.775</p_value>
            <p_value_desc>Analysis at 15 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.094</p_value>
            <p_value_desc>Analysis at 30 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.114</p_value>
            <p_value_desc>Analysis at 45 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis at 60 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 75 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 90 min
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) From 7 to 24 Hours Post-First Dose</title>
        <description>The Difficulty Swallowing Pain Intensity Difference (PID) was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
        <time_frame>7 to 24 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) From 7 to 24 Hours Post-First Dose</title>
          <description>The Difficulty Swallowing Pain Intensity Difference (PID) was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.91" spread="2.35"/>
                    <measurement group_id="O2" value="18.11" spread="3.32"/>
                    <measurement group_id="O3" value="11.38" spread="3.32"/>
                    <measurement group_id="O4" value="4.86" spread="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.53" spread="2.38"/>
                    <measurement group_id="O2" value="17.29" spread="3.37"/>
                    <measurement group_id="O3" value="13.40" spread="3.37"/>
                    <measurement group_id="O4" value="4.88" spread="2.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.59" spread="2.35"/>
                    <measurement group_id="O2" value="15.10" spread="3.32"/>
                    <measurement group_id="O3" value="12.68" spread="3.32"/>
                    <measurement group_id="O4" value="5.46" spread="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.61" spread="2.39"/>
                    <measurement group_id="O2" value="14.32" spread="3.38"/>
                    <measurement group_id="O3" value="11.68" spread="3.38"/>
                    <measurement group_id="O4" value="5.85" spread="2.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.01" spread="2.45"/>
                    <measurement group_id="O2" value="12.99" spread="3.46"/>
                    <measurement group_id="O3" value="13.13" spread="3.46"/>
                    <measurement group_id="O4" value="5.22" spread="2.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.40" spread="2.51"/>
                    <measurement group_id="O2" value="11.44" spread="3.55"/>
                    <measurement group_id="O3" value="13.41" spread="3.55"/>
                    <measurement group_id="O4" value="5.30" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.25" spread="2.70"/>
                    <measurement group_id="O2" value="13.67" spread="3.83"/>
                    <measurement group_id="O3" value="13.24" spread="3.82"/>
                    <measurement group_id="O4" value="8.79" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 8 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <p_value_desc>Analysis at 9 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>Analysis at 10 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.033</p_value>
            <p_value_desc>Analysis at 11 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.036</p_value>
            <p_value_desc>Analysis at 12 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.500</p_value>
            <p_value_desc>Analysis at 24 hours
Overall P-value</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Sum of Sore Throat Pain Intensity Difference (SPID2) as Measured by Difficulty Swallowing Scale (DSS) at 2 Hours Post-First Dose</title>
        <description>SPID2 was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS scale: 0mm=not difficult, 100mm=very difficult) at 2 hours post dose and at baseline.</description>
        <time_frame>Over 2 hour Period Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Sore Throat Pain Intensity Difference (SPID2) as Measured by Difficulty Swallowing Scale (DSS) at 2 Hours Post-First Dose</title>
          <description>SPID2 was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS scale: 0mm=not difficult, 100mm=very difficult) at 2 hours post dose and at baseline.</description>
          <population>MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" spread="2.73"/>
                    <measurement group_id="O2" value="16.0" spread="2.73"/>
                    <measurement group_id="O3" value="5.8" spread="2.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>16.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>8.5</ci_lower_limit>
            <ci_upper_limit>23.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>10.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>2.6</ci_lower_limit>
            <ci_upper_limit>17.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.127</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-5.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-13.5</ci_lower_limit>
            <ci_upper_limit>1.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Sum of Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) Within 6 Hours Post-First Dose</title>
        <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
        <time_frame>Within 6 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) Within 6 Hours Post-First Dose</title>
          <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 90-85 for 50mg/50mg; 90-87 for 100mg (pooled); 89-85 for Placebo.
MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.3"/>
                    <measurement group_id="O2" value="0.7" spread="0.3"/>
                    <measurement group_id="O3" value="0.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="0.6"/>
                    <measurement group_id="O2" value="1.8" spread="0.6"/>
                    <measurement group_id="O3" value="0.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="1.0"/>
                    <measurement group_id="O2" value="3.5" spread="1.0"/>
                    <measurement group_id="O3" value="1.6" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="1.4"/>
                    <measurement group_id="O2" value="5.8" spread="1.4"/>
                    <measurement group_id="O3" value="2.6" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" spread="1.8"/>
                    <measurement group_id="O2" value="8.7" spread="1.8"/>
                    <measurement group_id="O3" value="3.6" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.75 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" spread="2.2"/>
                    <measurement group_id="O2" value="12.1" spread="2.2"/>
                    <measurement group_id="O3" value="4.6" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" spread="2.7"/>
                    <measurement group_id="O2" value="16.0" spread="2.7"/>
                    <measurement group_id="O3" value="5.8" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.9" spread="4.8"/>
                    <measurement group_id="O2" value="33.5" spread="4.8"/>
                    <measurement group_id="O3" value="10.4" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.3" spread="6.8"/>
                    <measurement group_id="O2" value="51.8" spread="6.8"/>
                    <measurement group_id="O3" value="16.1" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.8" spread="9.0"/>
                    <measurement group_id="O2" value="70.0" spread="9.0"/>
                    <measurement group_id="O3" value="22.8" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.3" spread="11.0"/>
                    <measurement group_id="O2" value="87.3" spread="11.0"/>
                    <measurement group_id="O3" value="28.6" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.480</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.780</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.667</p_value>
            <p_value_desc>Analysis at 15 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.153</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.479</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.469</p_value>
            <p_value_desc>Analysis at 30 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.062</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.284</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.421</p_value>
            <p_value_desc>Analysis at 45 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.022</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.171</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.354</p_value>
            <p_value_desc>Analysis at 60 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.090</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.262</p_value>
            <p_value_desc>Analysis at 75 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.044</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.194</p_value>
            <p_value_desc>Analysis at 90 min
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.020</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.148</p_value>
            <p_value_desc>Analysis at 1.75 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.127</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.122</p_value>
            <p_value_desc>Analysis at 3 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.164</p_value>
            <p_value_desc>Analysis at 4 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.244</p_value>
            <p_value_desc>Analysis at 5 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.336</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Sum of Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) From 7 to 24 Hours Post-First Dose</title>
        <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
        <time_frame>7 to 24 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Sum of Difficulty Swallowing Difference as Measured by Difficulty Swallowing Scale (DSS) From 7 to 24 Hours Post-First Dose</title>
          <description>The sum of pain intensity differences (SPID) was calculated as the AUC of the Pain Intensity Difference (PID) scores. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS range: 0mm=not difficult, 100mm=very difficult) at the time and at baseline.</description>
          <population>Subjects evaluated at each timepoint varied from: 85-80 for 50mg/50mg; 43-39 for 100mg/Placebo; 44-43 for 100mg/50mg; 82-73 for Placebo.
MITT population</population>
          <units>units on a scale * hours</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119.1" spread="13.0"/>
                    <measurement group_id="O2" value="133.6" spread="18.3"/>
                    <measurement group_id="O3" value="72.2" spread="18.3"/>
                    <measurement group_id="O4" value="33.9" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135.8" spread="15.0"/>
                    <measurement group_id="O2" value="151.3" spread="21.3"/>
                    <measurement group_id="O3" value="84.5" spread="21.3"/>
                    <measurement group_id="O4" value="38.8" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152.3" spread="17.1"/>
                    <measurement group_id="O2" value="167.5" spread="24.2"/>
                    <measurement group_id="O3" value="97.6" spread="24.2"/>
                    <measurement group_id="O4" value="43.9" spread="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.9" spread="19.1"/>
                    <measurement group_id="O2" value="182.2" spread="27.0"/>
                    <measurement group_id="O3" value="109.8" spread="27.0"/>
                    <measurement group_id="O4" value="49.6" spread="19.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="184.7" spread="21.1"/>
                    <measurement group_id="O2" value="195.8" spread="29.9"/>
                    <measurement group_id="O3" value="122.2" spread="29.9"/>
                    <measurement group_id="O4" value="55.1" spread="21.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200.0" spread="23.2"/>
                    <measurement group_id="O2" value="208.0" spread="32.8"/>
                    <measurement group_id="O3" value="135.4" spread="32.8"/>
                    <measurement group_id="O4" value="60.4" spread="23.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="377.9" spread="50.4"/>
                    <measurement group_id="O2" value="358.7" spread="71.3"/>
                    <measurement group_id="O3" value="295.3" spread="71.3"/>
                    <measurement group_id="O4" value="144.9" spread="50.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.090</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.518</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.038</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.019</p_value>
            <p_value_desc>Analysis at 7 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.081</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.552</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.050</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.027</p_value>
            <p_value_desc>Analysis at 8 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.071</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.609</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.065</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.042</p_value>
            <p_value_desc>Analysis at 9 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.070</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.689</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.075</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Continuous data were analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.059</p_value>
            <p_value_desc>Analysis at 10 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.069</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.762</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.089</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.083</p_value>
            <p_value_desc>Analysis at 11 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.064</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.841</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.110</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.119</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.087</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.826</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.345</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.530</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Difficulty Swallowing Scale (DSS) Difference at Least 50% Gone at 6 Hours Post-First Dose</title>
        <description>Number of Subjects with &gt;= 50% Pain Intensity Difference (PID) on the DSS. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS scale: 0mm=not difficult, 100mm=very difficult) at 6 hours and at baseline.</description>
        <time_frame>At 6 hours</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Difficulty Swallowing Scale (DSS) Difference at Least 50% Gone at 6 Hours Post-First Dose</title>
          <description>Number of Subjects with &gt;= 50% Pain Intensity Difference (PID) on the DSS. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS scale: 0mm=not difficult, 100mm=very difficult) at 6 hours and at baseline.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.149</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.73</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.8</ci_lower_limit>
            <ci_upper_limit>3.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.076</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.95</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>4.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.733</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.6</ci_lower_limit>
            <ci_upper_limit>2.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Difficulty Swallowing Scale (DSS) Difference at Least 50% Gone at 12 Hours Post-First Dose</title>
        <description>Number of Subjects with &gt;= 50% Pain Intensity Difference (PID) on the DSS. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS scale: 0mm=not difficult, 100mm=very difficult) at 12 hours and at baseline.</description>
        <time_frame>At 12 Hours</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Difficulty Swallowing Scale (DSS) Difference at Least 50% Gone at 12 Hours Post-First Dose</title>
          <description>Number of Subjects with &gt;= 50% Pain Intensity Difference (PID) on the DSS. The Difficulty Swallowing PID was calculated as the difference between the pain intensity (DSS scale: 0mm=not difficult, 100mm=very difficult) at 12 hours and at baseline.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.030</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.1</ci_lower_limit>
            <ci_upper_limit>5.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.064</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.0</ci_lower_limit>
            <ci_upper_limit>5.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.201</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.83</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.7</ci_lower_limit>
            <ci_upper_limit>4.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.575</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.27</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>3.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1.000</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>2.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.624</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.27</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>3.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Total Pain Relief (TOTPAR) at 2 and 6 Hours Post-First Dose</title>
        <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief).</description>
        <time_frame>2 and 6 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at 6 hours: 85 for 50mg/50mg; 87 for 100mg (pooled); 85 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Total Pain Relief (TOTPAR) at 2 and 6 Hours Post-First Dose</title>
          <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief).</description>
          <population>Subjects evaluated at 6 hours: 85 for 50mg/50mg; 87 for 100mg (pooled); 85 for Placebo.
MITT population</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="0.2"/>
                    <measurement group_id="O2" value="2.2" spread="0.2"/>
                    <measurement group_id="O3" value="1.3" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6" spread="0.8"/>
                    <measurement group_id="O2" value="9.9" spread="0.8"/>
                    <measurement group_id="O3" value="5.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.28</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.7</ci_lower_limit>
            <ci_upper_limit>1.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.3</ci_lower_limit>
            <ci_upper_limit>1.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.177</p_value>
            <p_value_desc>Analysis at 2 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.40</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-1.0</ci_lower_limit>
            <ci_upper_limit>0.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5.25</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>3.0</ci_lower_limit>
            <ci_upper_limit>7.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>4.54</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>2.3</ci_lower_limit>
            <ci_upper_limit>6.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.531</p_value>
            <p_value_desc>Analysis at 6 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-3.0</ci_lower_limit>
            <ci_upper_limit>1.5</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Total Pain Relief (TOTPAR) at 12 and 24 Hours Post-First Dose</title>
        <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief).</description>
        <time_frame>12 and 24 hours Post-First Dose</time_frame>
        <population>Subjects evaluated at 24 hours: 84 for 50mg/50mg; 43 for 100mg/Placebo; 44 for 100mg/50mg; 81 for Placebo.
MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg /Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Total Pain Relief (TOTPAR) at 12 and 24 Hours Post-First Dose</title>
          <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief).</description>
          <population>Subjects evaluated at 24 hours: 84 for 50mg/50mg; 43 for 100mg/Placebo; 44 for 100mg/50mg; 81 for Placebo.
MITT population</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="81"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.6" spread="1.7"/>
                    <measurement group_id="O2" value="22.0" spread="2.4"/>
                    <measurement group_id="O3" value="17.5" spread="2.4"/>
                    <measurement group_id="O4" value="11.6" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.9" spread="3.6"/>
                    <measurement group_id="O2" value="41.5" spread="5.1"/>
                    <measurement group_id="O3" value="36.7" spread="5.1"/>
                    <measurement group_id="O4" value="27.3" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>9.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.4</ci_lower_limit>
            <ci_upper_limit>13.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>10.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.7</ci_lower_limit>
            <ci_upper_limit>16.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.041</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.2</ci_lower_limit>
            <ci_upper_limit>11.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.633</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-7.1</ci_lower_limit>
            <ci_upper_limit>4.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.284</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.11</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.6</ci_lower_limit>
            <ci_upper_limit>8.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.180</p_value>
            <p_value_desc>Analysis at 12 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>4.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.1</ci_lower_limit>
            <ci_upper_limit>11.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>13.57</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>3.4</ci_lower_limit>
            <ci_upper_limit>23.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.026</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>14.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.7</ci_lower_limit>
            <ci_upper_limit>26.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.138</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>9.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-3.0</ci_lower_limit>
            <ci_upper_limit>21.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.926</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.59</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-13.0</ci_lower_limit>
            <ci_upper_limit>11.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.507</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>4.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-8.2</ci_lower_limit>
            <ci_upper_limit>16.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.513</p_value>
            <p_value_desc>Analysis at 24 hours
Pairwise comparison. No adjustment made for multiplicity.</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Analyzed using a Generalized Linear Model with treatment as fixed effect and baseline score as a covariate</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>4.77</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-9.6</ci_lower_limit>
            <ci_upper_limit>19.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects With &gt;= 50% Total Pain Relief (TOTPAR) at 6 Hours Post-First Dose</title>
        <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief). Maximum TOTPAR over 6 hours is 36. If the subject calculated TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject is said to have achieved &gt;=50% TOTPAR.</description>
        <time_frame>6 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects With &gt;= 50% Total Pain Relief (TOTPAR) at 6 Hours Post-First Dose</title>
          <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief). Maximum TOTPAR over 6 hours is 36. If the subject calculated TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject is said to have achieved &gt;=50% TOTPAR.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.023</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>7.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>7.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.854</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>2.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects With &gt;= 50% Total Pain Relief (TOTPAR) at 12 Hours Post-First Dose</title>
        <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief). Maximum TOTPAR over 12 hours is 72. If the subject calculated TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject is said to have achieved &gt;=50% TOTPAR.</description>
        <time_frame>12 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects With &gt;= 50% Total Pain Relief (TOTPAR) at 12 Hours Post-First Dose</title>
          <description>TOTPAR is time-interval-weighted sum of accumulated Sore Throat Relief Rating Scale (STRRS) scores (scale: 0 no relief to 6 complete relief). Maximum TOTPAR over 12 hours is 72. If the subject calculated TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject is said to have achieved &gt;=50% TOTPAR.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.013</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.3</ci_lower_limit>
            <ci_upper_limit>9.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>5.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.7</ci_lower_limit>
            <ci_upper_limit>14.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.057</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.0</ci_lower_limit>
            <ci_upper_limit>9.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.758</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.16</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>2.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.381</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.69</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.3</ci_lower_limit>
            <ci_upper_limit>1.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.313</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.68</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.6</ci_lower_limit>
            <ci_upper_limit>4.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number Needed to Treat (NNT) to Achieve at Least 50% of Maximum Total Pain Relief (TOTPAR) at 6 Hours Post-First Dose</title>
        <description>NNT is number of subjects needed to treat to have one extra subject report a 50% or better pain relief over 6 hours based on maximum possible pain relief on Sore Throat Relief Rating Scale. Maximum TOTPAR over 6 hours is 36. If the subject TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject has achieved &gt;=50% TOTPAR.</description>
        <time_frame>6 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Number Needed to Treat (NNT) to Achieve at Least 50% of Maximum Total Pain Relief (TOTPAR) at 6 Hours Post-First Dose</title>
          <description>NNT is number of subjects needed to treat to have one extra subject report a 50% or better pain relief over 6 hours based on maximum possible pain relief on Sore Throat Relief Rating Scale. Maximum TOTPAR over 6 hours is 36. If the subject TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject has achieved &gt;=50% TOTPAR.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>NNT is the inverse of the absolute risk reduction at 6 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>NNT at 6 hours</param_type>
            <param_value>8.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.5</ci_lower_limit>
            <ci_upper_limit>46.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>NNT is the inverse of the absolute risk reduction at 6 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>NNT at 6 hours</param_type>
            <param_value>7.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.3</ci_lower_limit>
            <ci_upper_limit>32.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number Needed to Treat (NNT) to Achieve at Least 50% of Maximum Total Pain Relief (TOTPAR) at 12 Hours Post-First Dose</title>
        <description>NNT is number of subjects needed to treat to have one subject report a 50% or better pain relief over 12 hours based on maximum possible pain relief on Sore Throat Relief Rating Scale. Maximum TOTPAR over 12 hours is 72. If the subject TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject has achieved &gt;=50% TOTPAR.</description>
        <time_frame>12 hours Post-First Dose</time_frame>
        <population>MITT population Comparison Celecoxib 100mg/50mg - Placebo: the NNT value was non-estimable</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Number Needed to Treat (NNT) to Achieve at Least 50% of Maximum Total Pain Relief (TOTPAR) at 12 Hours Post-First Dose</title>
          <description>NNT is number of subjects needed to treat to have one subject report a 50% or better pain relief over 12 hours based on maximum possible pain relief on Sore Throat Relief Rating Scale. Maximum TOTPAR over 12 hours is 72. If the subject TOTPAR is greater than or equal to 50% of the maximum TOTPAR then the subject has achieved &gt;=50% TOTPAR.</description>
          <population>MITT population Comparison Celecoxib 100mg/50mg - Placebo: the NNT value was non-estimable</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>NNT is the inverse of the absolute risk reduction at 12 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>NNT at 12 hours</param_type>
            <param_value>7.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.3</ci_lower_limit>
            <ci_upper_limit>28.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>NNT is the inverse of the absolute risk reduction at 12 hours</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>NNT at 12 hours</param_type>
            <param_value>5.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>3.0</ci_lower_limit>
            <ci_upper_limit>16.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects With Sore Throat Pain at Least 35% Gone and at Least 50% Gone at 2 and 6 Hours Post-First Dose</title>
        <description>&gt;= 35% and 50% Pain Intensity Difference (PID) on the Pain Intensity-Visual Analog Scale (PI-VAS) (scale: 0mm=no pain, 100mm=worst possible pain). The PID was calculated as the difference between the pain intensity at the time and at baseline.</description>
        <time_frame>2 and 6 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Sore Throat Pain at Least 35% Gone and at Least 50% Gone at 2 and 6 Hours Post-First Dose</title>
          <description>&gt;= 35% and 50% Pain Intensity Difference (PID) on the Pain Intensity-Visual Analog Scale (PI-VAS) (scale: 0mm=no pain, 100mm=worst possible pain). The PID was calculated as the difference between the pain intensity at the time and at baseline.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="90"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 hours &gt;=35% gone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours &gt;=35% gone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours &gt;=50% gone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours &gt;=50% gone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis for 2 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.77</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.9</ci_lower_limit>
            <ci_upper_limit>7.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Analysis for 2 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.3</ci_lower_limit>
            <ci_upper_limit>5.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.286</p_value>
            <p_value_desc>Analysis for 2 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>1.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis for 6 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.6</ci_lower_limit>
            <ci_upper_limit>7.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <p_value_desc>Analysis for 6 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.05</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.4</ci_lower_limit>
            <ci_upper_limit>6.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.752</p_value>
            <p_value_desc>Analysis for 6 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>1.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis for 2 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>4.57</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.9</ci_lower_limit>
            <ci_upper_limit>10.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis for 2 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.68</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.6</ci_lower_limit>
            <ci_upper_limit>8.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.511</p_value>
            <p_value_desc>Analysis for 2 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>1.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>Analysis for 6 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.05</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.3</ci_lower_limit>
            <ci_upper_limit>7.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.014</p_value>
            <p_value_desc>Analysis for 6 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>6.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.863</p_value>
            <p_value_desc>Analysis for 6 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>1.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects With Sore Throat Pain at Least 35% Gone and at Least 50% Gone at 12 Hours Post-First Dose</title>
        <description>&gt;= 35% and 50% Pain Intensity Difference (PID) on the Pain Intensity-Visual Analog Scale (PI-VAS) (scale: 0mm=no pain, 100mm=worst possible pain). The PID was calculated as the difference between the pain intensity at 12 hours and at baseline.</description>
        <time_frame>12 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Sore Throat Pain at Least 35% Gone and at Least 50% Gone at 12 Hours Post-First Dose</title>
          <description>&gt;= 35% and 50% Pain Intensity Difference (PID) on the Pain Intensity-Visual Analog Scale (PI-VAS) (scale: 0mm=no pain, 100mm=worst possible pain). The PID was calculated as the difference between the pain intensity at 12 hours and at baseline.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 hours &gt;=35% gone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours &gt;=50% gone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <p_value_desc>12 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.92</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.4</ci_lower_limit>
            <ci_upper_limit>6.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.052</p_value>
            <p_value_desc>12 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.0</ci_lower_limit>
            <ci_upper_limit>5.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.095</p_value>
            <p_value_desc>12 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>5.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.431</p_value>
            <p_value_desc>12 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.38</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.6</ci_lower_limit>
            <ci_upper_limit>3.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.602</p_value>
            <p_value_desc>12 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.6</ci_lower_limit>
            <ci_upper_limit>2.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.814</p_value>
            <p_value_desc>12 hours &gt;=35% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>2.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.014</p_value>
            <p_value_desc>12 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>6.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.016</p_value>
            <p_value_desc>12 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>8.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.063</p_value>
            <p_value_desc>12 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.54</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>6.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.775</p_value>
            <p_value_desc>12 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>2.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.779</p_value>
            <p_value_desc>12 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>2.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.624</p_value>
            <p_value_desc>12 hours &gt;=50% gone</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.27</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>3.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' and 'Much Improvement' at 2 and 6 Hours Post-First Dose</title>
        <description>Symptom relief measured as self-directed endpoints defined by each individual at end of study using Sore Throat Relief Rating Scale (STRRS); STRRS score ranges from 0=no relief to 6=complete relief. If subject scored same or greater in their STRRS during the study then they achieved their 'Meaningful Relief' or 'Much Improvement'.</description>
        <time_frame>2 and 6 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' and 'Much Improvement' at 2 and 6 Hours Post-First Dose</title>
          <description>Symptom relief measured as self-directed endpoints defined by each individual at end of study using Sore Throat Relief Rating Scale (STRRS); STRRS score ranges from 0=no relief to 6=complete relief. If subject scored same or greater in their STRRS during the study then they achieved their 'Meaningful Relief' or 'Much Improvement'.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>meaningful relief - 2 hours- achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>meaningful relief- 2 hours- not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="63"/>
                    <measurement group_id="O3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>meaningful relief - 6 hours- achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>meaningful relief- 6 hours- not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>much improvement - 2 hours- achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>much improvement - 2 hours- not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="67"/>
                    <measurement group_id="O3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>much improvement - 6 hours- achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>much improvement - 6 hours- not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis for meaningful Relief at 2 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Analysis for meaningful Relief at 2 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.453</p_value>
            <p_value_desc>Analysis for meaningful Relief at 2 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis for meaningful Relief at 6 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis for meaningful Relief at 6 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.814</p_value>
            <p_value_desc>Analysis for meaningful Relief at 6 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.024</p_value>
            <p_value_desc>Analysis for Much Improvement at 2 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.022</p_value>
            <p_value_desc>Analysis for Much Improvement at 2 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.966</p_value>
            <p_value_desc>Analysis for Much Improvement at 2 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis for Much Improvement at 6 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis for Much Improvement at 6 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.798</p_value>
            <p_value_desc>Analysis for Much Improvement at 6 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' and 'Much Improvement' at 12 Hours Post-First Dose</title>
        <description>Symptom relief measured as self-directed endpoints defined by each individual at end of study using Sore Throat Relief Rating Scale (STRRS); STRRS score ranges from 0=no relief to 6=complete relief. If subject scored same or greater in their STRRS during the study then they achieved their 'Meaningful Relief' or 'Much Improvement'.</description>
        <time_frame>12 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg /Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' and 'Much Improvement' at 12 Hours Post-First Dose</title>
          <description>Symptom relief measured as self-directed endpoints defined by each individual at end of study using Sore Throat Relief Rating Scale (STRRS); STRRS score ranges from 0=no relief to 6=complete relief. If subject scored same or greater in their STRRS during the study then they achieved their 'Meaningful Relief' or 'Much Improvement'.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Meaningful Relief - achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Meaningful Relief - not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Much Improvement - achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Much Improvement - not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis for Meaningful Relief</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis for Meaningful Relief</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Analysis for Meaningful Relief</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.709</p_value>
            <p_value_desc>Analysis for Meaningful Relief</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.331</p_value>
            <p_value_desc>Analysis for Meaningful Relief</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.246</p_value>
            <p_value_desc>Analysis for Meaningful Relief</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Analysis for Much Improvement</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis for Much Improvement</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.219</p_value>
            <p_value_desc>Analysis for Much Improvement</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.095</p_value>
            <p_value_desc>Analysis for Much Improvement</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.463</p_value>
            <p_value_desc>Analysis for Much Improvement</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.038</p_value>
            <p_value_desc>Analysis for Much Improvement</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Who Had Perceptible Relief Onset Time Within 1 Hour</title>
        <description>At end of study subjects defined meaningful pain relief by completing Meaningful Relief Scale. Meaningful relief was achieved if Sore Throat Relief Rating Scale (STRRS) score (range: 0=no relief to 6=complete relief) at end of the study was the same or higher than individually defined relief score during the study. Perceptible relief is STRRS &gt;0.</description>
        <time_frame>Within 6 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Who Had Perceptible Relief Onset Time Within 1 Hour</title>
          <description>At end of study subjects defined meaningful pain relief by completing Meaningful Relief Scale. Meaningful relief was achieved if Sore Throat Relief Rating Scale (STRRS) score (range: 0=no relief to 6=complete relief) at end of the study was the same or higher than individually defined relief score during the study. Perceptible relief is STRRS &gt;0.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="89"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="62"/>
                    <measurement group_id="O3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.557</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Who Still Had Perceptible Relief at 12 and 24 Hours Post-First Dose</title>
        <description>At end of study subjects defined meaningful pain relief by completing the Meaningful Relief Scale. Meaningful relief was achieved if Sore Throat Relief Rating Scale (STRRS)(range: 0=no relief to 6=complete relief) score at end of the study was the same or higher than individually defined relief score during the study. Perceptible relief is STRRS &gt;0</description>
        <time_frame>12 and 24 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Who Still Had Perceptible Relief at 12 and 24 Hours Post-First Dose</title>
          <description>At end of study subjects defined meaningful pain relief by completing the Meaningful Relief Scale. Meaningful relief was achieved if Sore Throat Relief Rating Scale (STRRS)(range: 0=no relief to 6=complete relief) score at end of the study was the same or higher than individually defined relief score during the study. Perceptible relief is STRRS &gt;0</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>at 12 hours - Achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 12 hours - Not Achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 24 hours - Achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 24 hours - Not Achieved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis at 12 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 12 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.036</p_value>
            <p_value_desc>Analysis at 12 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.339</p_value>
            <p_value_desc>Analysis at 12 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1.000</p_value>
            <p_value_desc>Analysis at 12 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.401</p_value>
            <p_value_desc>Analysis at 12 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis at 24 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Analysis at 24 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.223</p_value>
            <p_value_desc>Analysis at 24 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.198</p_value>
            <p_value_desc>Analysis at 24 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.604</p_value>
            <p_value_desc>Analysis at 24 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.117</p_value>
            <p_value_desc>Analysis at 24 hours</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Median Onset Time of First Perceptible Relief in Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Post-First Dose</title>
        <description>Perceptible Relief is score &gt;0 on STRRS. Individual level of meaningful relief had to be reached within 6 hours. Meaningful Relief was achieved if Sore Throat Relief Rating Scale (STRRS)(range: 0=no relief to 6=complete relief)score at the end of the study was the same or higher than individually defined meaningful relief score during the study.</description>
        <time_frame>24 Hours</time_frame>
        <population>Number of subjects who achieved meaningful relief within 6 hours</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg (Pooled)</title>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Median Onset Time of First Perceptible Relief in Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Post-First Dose</title>
          <description>Perceptible Relief is score &gt;0 on STRRS. Individual level of meaningful relief had to be reached within 6 hours. Meaningful Relief was achieved if Sore Throat Relief Rating Scale (STRRS)(range: 0=no relief to 6=complete relief)score at the end of the study was the same or higher than individually defined meaningful relief score during the study.</description>
          <population>Number of subjects who achieved meaningful relief within 6 hours</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" lower_limit="0.25" upper_limit="3.00"/>
                    <measurement group_id="O2" value="0.63" lower_limit="0.25" upper_limit="1.50"/>
                    <measurement group_id="O3" value="0.50" lower_limit="0.25" upper_limit="6.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Median Offset Time of No Perceptible Relief in Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Post-First Dose</title>
        <description>Offset time is time of first no perceptible relief (STRRS score=0) with meaningful relief (score&gt;0) at earlier time. STRRS score ranges from 0=no relief to 6=complete relief.</description>
        <time_frame>24 Hours</time_frame>
        <population>Number of subjects who achieved Meaningful Relief within 6 hours</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Median Offset Time of No Perceptible Relief in Subjects Who Achieved Their Own Level of 'Meaningful Relief' Within 6 Hours Post-First Dose</title>
          <description>Offset time is time of first no perceptible relief (STRRS score=0) with meaningful relief (score&gt;0) at earlier time. STRRS score ranges from 0=no relief to 6=complete relief.</description>
          <population>Number of subjects who achieved Meaningful Relief within 6 hours</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.00" lower_limit="3.00" upper_limit="24.00"/>
                    <measurement group_id="O2" value="8.00" lower_limit="1.25" upper_limit="9.00"/>
                    <measurement group_id="O3" value="8.00" lower_limit="3.00" upper_limit="24.00"/>
                    <measurement group_id="O4" value="10.00" lower_limit="2.00" upper_limit="12.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Treatment Failures on STRRS Questionnaire</title>
        <description>Subjects were considered treatment failures if all of the STRRS scores were less than each individual's 'meaningful relief' scores. STRRS score ranges from 0=no relief to 6=complete relief.</description>
        <time_frame>24 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Treatment Failures on STRRS Questionnaire</title>
          <description>Subjects were considered treatment failures if all of the STRRS scores were less than each individual's 'meaningful relief' scores. STRRS score ranges from 0=no relief to 6=complete relief.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Not treatment failures</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment failures</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.025</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.539</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.329</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.171</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subjects Taking Rescue Medication</title>
        <description>Subjects were allowed to use rescue medication at any time during the trial, but were discouraged from taking rescue medication within 2 hours of administration of the first dose of study drug.</description>
        <time_frame>Within 24 hours Post-First Dose</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg /Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Subjects Taking Rescue Medication</title>
          <description>Subjects were allowed to use rescue medication at any time during the trial, but were discouraged from taking rescue medication within 2 hours of administration of the first dose of study drug.</description>
          <population>MITT population</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.244</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.096</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.579</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.277</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.649</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Treatment as a factor</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Treatment Satisfaction Questionnaire for Medication (TSQM vII)</title>
        <description>11 questions scored on factors: effectiveness, side effects, convenience, overall satisfaction. TSQM vII scores range 0 to 100, with higher scores indicating a higher level of global satisfaction with treatment.</description>
        <time_frame>24 hours or immediately prior to taking rescue medication</time_frame>
        <population>MITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg /Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>Treatment Satisfaction Questionnaire for Medication (TSQM vII)</title>
          <description>11 questions scored on factors: effectiveness, side effects, convenience, overall satisfaction. TSQM vII scores range 0 to 100, with higher scores indicating a higher level of global satisfaction with treatment.</description>
          <population>MITT population</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Effectiveness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.5" spread="26.6"/>
                    <measurement group_id="O2" value="40.6" spread="28.7"/>
                    <measurement group_id="O3" value="34.3" spread="26.2"/>
                    <measurement group_id="O4" value="26.1" spread="25.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Side Effects</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.3" spread="12.0"/>
                    <measurement group_id="O2" value="96.7" spread="11.6"/>
                    <measurement group_id="O3" value="97.9" spread="9.7"/>
                    <measurement group_id="O4" value="98.6" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Convenience</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.2" spread="15.1"/>
                    <measurement group_id="O2" value="73.0" spread="17.4"/>
                    <measurement group_id="O3" value="69.3" spread="16.8"/>
                    <measurement group_id="O4" value="71.3" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Global Satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.1" spread="28.0"/>
                    <measurement group_id="O2" value="47.8" spread="33.4"/>
                    <measurement group_id="O3" value="42.2" spread="30.6"/>
                    <measurement group_id="O4" value="36.0" spread="27.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Analysis of Effectiveness</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>15.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>7.5</ci_lower_limit>
            <ci_upper_limit>23.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis of Effectiveness</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>14.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.9</ci_lower_limit>
            <ci_upper_limit>24.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.096</p_value>
            <p_value_desc>Analysis of Effectiveness</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>8.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-1.5</ci_lower_limit>
            <ci_upper_limit>17.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.141</p_value>
            <p_value_desc>Analysis of Effectiveness</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.4</ci_lower_limit>
            <ci_upper_limit>16.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.849</p_value>
            <p_value_desc>Analysis of Effectiveness</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-8.6</ci_lower_limit>
            <ci_upper_limit>10.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.266</p_value>
            <p_value_desc>Analysis of Effectiveness</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>6.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.8</ci_lower_limit>
            <ci_upper_limit>17.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.141</p_value>
            <p_value_desc>Analysis of Side Effects</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-5.4</ci_lower_limit>
            <ci_upper_limit>0.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.312</p_value>
            <p_value_desc>Analysis of Side Effects</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-5.7</ci_lower_limit>
            <ci_upper_limit>1.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.724</p_value>
            <p_value_desc>Analysis of Side Effects</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.5</ci_lower_limit>
            <ci_upper_limit>3.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.398</p_value>
            <p_value_desc>Analysis of Side Effects</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-5.4</ci_lower_limit>
            <ci_upper_limit>2.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.846</p_value>
            <p_value_desc>Analysis of Side Effects</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.1</ci_lower_limit>
            <ci_upper_limit>3.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.572</p_value>
            <p_value_desc>Analysis of Side Effects</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-5.6</ci_lower_limit>
            <ci_upper_limit>3.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.014</p_value>
            <p_value_desc>Analysis of Convenience</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>10.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.573</p_value>
            <p_value_desc>Analysis of Convenience</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.0</ci_lower_limit>
            <ci_upper_limit>7.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.482</p_value>
            <p_value_desc>Analysis of Convenience</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-7.7</ci_lower_limit>
            <ci_upper_limit>3.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <p_value_desc>Analysis of Convenience</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>2.2</ci_lower_limit>
            <ci_upper_limit>13.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.143</p_value>
            <p_value_desc>Analysis of Convenience</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-1.4</ci_lower_limit>
            <ci_upper_limit>9.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.273</p_value>
            <p_value_desc>Analysis of Convenience</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.9</ci_lower_limit>
            <ci_upper_limit>10.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Analysis of Global Satisfaction</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>13.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>4.4</ci_lower_limit>
            <ci_upper_limit>21.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.029</p_value>
            <p_value_desc>Analysis of Global Satisfaction</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>11.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>22.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.251</p_value>
            <p_value_desc>Analysis of Global Satisfaction</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>6.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.4</ci_lower_limit>
            <ci_upper_limit>16.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.204</p_value>
            <p_value_desc>Analysis of Global Satisfaction</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>6.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-3.7</ci_lower_limit>
            <ci_upper_limit>17.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.808</p_value>
            <p_value_desc>Analysis of Global Satisfaction</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-9.2</ci_lower_limit>
            <ci_upper_limit>11.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.371</p_value>
            <p_value_desc>Analysis of Global Satisfaction</p_value_desc>
            <method>Generalized linear model</method>
            <method_desc>Treatment as a fixed effect</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>5.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-6.6</ci_lower_limit>
            <ci_upper_limit>17.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>First Perceptible Relief</title>
        <description>Subjects having First Perceptible Relief at each time point. Perceptible relief is score &gt;0 on Sore Throat Relief Rating Scale(STRRS)(range: 0=no relief to 6=complete relief).</description>
        <time_frame>up to 24 hours</time_frame>
        <population>MITT population
Number of subjects assessed at each hour is: N = Celecoxib 50mg/50mg, Celecoxib 100mg/Placebo, Celecoxib 100mg/50mg, Placebo</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>First Perceptible Relief</title>
          <description>Subjects having First Perceptible Relief at each time point. Perceptible relief is score &gt;0 on Sore Throat Relief Rating Scale(STRRS)(range: 0=no relief to 6=complete relief).</description>
          <population>MITT population
Number of subjects assessed at each hour is: N = Celecoxib 50mg/50mg, Celecoxib 100mg/Placebo, Celecoxib 100mg/50mg, Placebo</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 hour - Onset subjects in hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour - No onset subjects in hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hour - Onset subjects in hour (N=22, 16, 23, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hour-No onset subjects in hour (N=22,16, 23, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hour - Onset subjects in hour (N=9, 6, 14, 38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hour-No onset subjects in hour (N=9, 6, 14, 38)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hour - Onset subjects in hour (N=8, 4, 14, 36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hour- No onset subjects in hour (N=8, 4, 14, 36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hour - Onset subjects in hour (N=8, 4, 12, 32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hour-No onset subjects in hour (N=8, 4, 12, 32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour - Onset subjects in hour (N=8, 4, 11, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour-No onset subjects in hour (N=8, 4, 11, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hour - Onset subjects in hour (N=8, 3, 8, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hour-No onset subjects in hour (N=8, 3, 8, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hour - Onset subjects in hour (N=8, 3, 7, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hour-No onset subjects in hour (N=8, 3, 7, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hour - Onset subjects in hour (N=8, 3, 6, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hour-No onset subjects in hour (N=8, 3, 6, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hour - Onset subjects in hour (N=6, 3, 6, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hour-No onset subjects in hour (N=6, 3, 6, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hour - Onset subjects in hour (N=6, 3, 6, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hour-No onset subjects in hour (N=6, 3, 6, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour - Onset subjects in hour (N=6, 3, 6, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour-No onset subjects in hour (N=6, 3, 6, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour - Onset subjects in hour (N=6, 3, 6, 20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour-No onset subjects in hour (N=6, 3, 6, 20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.235</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.438</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.067</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>No Perceptible Relief</title>
        <description>Subjects having No Perceptible Relief at each time point. No Perceptible relief is score = 0 on Sore Throat Relief Rating Scale (STRRS)(range: 0=no relief to 6=complete relief).</description>
        <time_frame>up to 24 hours</time_frame>
        <population>MITT population
Number of subjects at each time point (in hour) is: N = Celecoxib 50mg/50mg, Celecoxib 100mg/Placebo, Celecoxib 100mg/50mg, Placebo</population>
        <group_list>
          <group group_id="O1">
            <title>Celecoxib 50mg/50mg</title>
          </group>
          <group group_id="O2">
            <title>Celecoxib 100mg/Placebo</title>
          </group>
          <group group_id="O3">
            <title>Celecoxib 100mg/50mg</title>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
          </group>
        </group_list>
        <measure>
          <title>No Perceptible Relief</title>
          <description>Subjects having No Perceptible Relief at each time point. No Perceptible relief is score = 0 on Sore Throat Relief Rating Scale (STRRS)(range: 0=no relief to 6=complete relief).</description>
          <population>MITT population
Number of subjects at each time point (in hour) is: N = Celecoxib 50mg/50mg, Celecoxib 100mg/Placebo, Celecoxib 100mg/50mg, Placebo</population>
          <units>subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 hour - Offset subjects in hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour-No offset subjects in hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hour- Offset subjects in hour (N=90, 45, 45, 89)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hour-No offset subjects in hr (N=90, 45, 45, 89)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hour- Offset subjects in hour (N=90, 44, 45, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hour-No offset subjects in hr (N=90, 44, 45, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hour- Offset subjects in hour (N=89, 44, 44, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hour-No offset subjects in hr (N=89, 44, 44, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hour- Offset subjects in hour (N=89, 44, 44, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hour-No offset subjects in hr (N=89, 44, 44, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour- Offset subjects in hour (N=88, 44, 44, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour-No offset subjects in hr (N=88, 44, 44, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hour- Offset subjects in hour (N=88, 44, 44, 87)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hour-No offset subjects in hr (N=88, 44, 44, 87)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                    <measurement group_id="O2" value="42"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hour- Offset subjects in hour (N=84, 42, 42, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hour-No offset subjects in hr (N=84, 42, 42, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                    <measurement group_id="O2" value="40"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hour- Offset subjects in hour (N=83, 40, 42, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hour-No offset subjects in hr (N=83, 40, 42, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hour-Offset subjects in hour (N=82, 37, 41, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hour-No offset subjects in hr (N=82,37,41, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hour-Offset subjects in hour (N=80,37, 41, 83)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hour-No offset subjects in hr (N=80,37,41, 83)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour-Offset subjects in hour (N=79,37,41, 83)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour-No offset subjects in hr (N=79,37,41, 83)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour-Offset subjects in hour (N=78,37, 41, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour-No offset subjects in hr (N=78,37,41, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.128</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.123</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.266</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.849</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.828</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.741</p_value>
            <p_value_desc>Based on life-table extension of Mantel-Haenszel method.
p-value for general association</p_value_desc>
            <method>Mantel Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Celecoxib 50mg/50mg</title>
          <description>Dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
        </group>
        <group group_id="E2">
          <title>Celecoxib 100mg/Placebo</title>
          <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 placebo</description>
        </group>
        <group group_id="E3">
          <title>Celecoxib 100mg/50mg</title>
          <description>Dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 celecoxib 50 mg</description>
        </group>
        <group group_id="E4">
          <title>Placebo</title>
          <description>Dose 1 placebo followed 6-12 hours later by dose 2 placebo</description>
        </group>
      </group_list>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of &lt;60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), &lt;12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.govCallCenter@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

